Long-term Graft and Patient Survival in Kidney Transplant Recipients With High Levels of Preformed DSAs (MFI > 3000): A Propensity Score–matched Analysis
Sign Up to like & getrecommendations! Published in 2025 at "Transplantation Direct"
DOI: 10.1097/txd.0000000000001868
Abstract: Background. Kidney transplant recipients with preformed donor-specific antibodies (DSAs) are at higher risk for antibody-mediated rejection (AMR) and graft failure. This study assesses outcomes during a 15-y period, comparing patients with high levels of preformed… read more here.
Keywords: preformed dsas; survival; patients high; long term ... See more keywords
Preformed donor‐specific antibodies do not affect the 1‐year allograft survival in living donor liver transplantation
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Transplantation"
DOI: 10.1111/ctr.13244
Abstract: The effect of preformed donor‐specific antibodies (DSAs) on liver transplantation (LT) remains unclear, especially in the field of living donor LT (LDLT). Herein, we evaluated the prevalence of preformed DSAs and their effect on graft… read more here.
Keywords: year; preformed dsas; transplantation; preformed donor ... See more keywords